World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
33094
World Ranking
16426
National Ranking
1501

Overview

Allan Hackshaw is affiliated with University College London in the United Kingdom. Their research primarily focuses on medicine, with significant contributions to pulmonary and respiratory medicine, oncology, cancer research, radiology, nuclear medicine and imaging, and surgery.

Their work has been published extensively, with frequent appearance in key scientific venues including:

  • Lung Cancer
  • "The 'biomedical & life sciences collection."
  • Nature
  • Annals of Oncology
  • Cancer Research

Hackshaw's research covers various topics relevant to cancer and medical diagnostics such as:

  • Lung Cancer Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Lung Cancer Treatments and Mutations
  • Radiomics and Machine Learning in Medical Imaging
  • Global Cancer Incidence and Screening
  • Colorectal Cancer Screening and Detection
  • Cancer Immunotherapy and Biomarkers

Among the recent papers published by Allan Hackshaw are:

  • "Lung adenocarcinoma promotion by air pollutants," 2023, Nature
  • "Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA," 2023, Nature
  • "Geospatial immune variability illuminates differential evolution of lung adenocarcinoma," 2020, Nature Medicine
  • "The evolution of lung cancer and impact of subclonal selection in TRACERx," 2023, Nature
  • "Antibodies against endogenous retroviruses promote lung cancer immunotherapy," 2023, Nature

Hackshaw has collaborated frequently with several researchers, including:

  • Sam M. Janes (39 coauthored publications)
  • Laura Farrelly (33 coauthored publications)
  • Selvaraju Veeriah (29 coauthored publications)
  • Jennifer Dickson (29 coauthored publications)
  • Helen Hall (29 coauthored publications)

Best Publications

  • Tracking the Evolution of Non–Small-Cell Lung Cancer

    Mariam Jamal-Hanjani;Gareth A. Wilson;Nicholas McGranahan;Nicolai Juul Birkbak

  • Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

    Christopher Abbosh;Nicolai J. Birkbak;Nicolai J. Birkbak;Gareth A. Wilson;Gareth A. Wilson;Mariam Jamal-Hanjani

  • Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution

    Nicholas McGranahan;Rachel Rosenthal;Crispin T. Hiley;Crispin T. Hiley;Andrew J. Rowan

  • The accumulated evidence on lung cancer and environmental tobacco smoke.

    A K Hackshaw;M R Law;N J Wald

  • First and Second Trimester Antenatal Screening for Down's Syndrome: The Results of the Serum, Urine and Ultrasound Screening Study (SURUSS):

    N J Wald;C Rodeck;A K Hackshaw;J Walters

  • Tobacco and cancer: recent epidemiological evidence.

    Paolo Vineis;M. Alavanja;P. Buffler;E. Fontham

  • First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS).

    N J Wald;C Rodeck;A K Hackshaw;J Walters

  • Integrated Screening for Down’s Syndrome Based on Tests Performed During the First and Second Trimesters

    N. J. Wald;H. C. Watt;A. K. Hackshaw

  • Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls

    Allan Hackshaw;Charles Rodeck;Sadie Boniface

  • Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer

    Ujjal Mallick;Clive Harmer;Beng K. Yap;Jonathan Wadsley

  • Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports.

    Allan Hackshaw;Joan K Morris;Sadie Boniface;Jin-Ling Tang

  • Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR.

    Sara Ghorashian;Anne Marijn Kramer;Shimobi Onuoha;Gary Wright

  • Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies

    Frederick Arce Vargas;Andrew J S Furness;Kevin Litchfield;Kroopa Joshi

  • European Code Against Cancer and scientific justification: third version (2003)

    P. Boyle;P. Autier;H. Bartelink;J. Baselga

  • When can a risk factor be used as a worthwhile screening test

    N J Wald;A K Hackshaw;C D Frost

  • Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors.

    Frederick Arce Vargas;Andrew J.S. Furness;Andrew J.S. Furness;Isabelle Solomon;Kroopa Joshi;Kroopa Joshi

  • Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study.

    M R Law;N J Wald;T Wu;A Hackshaw

  • A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer.

    L. Kadalayil;R. Benini;L. Pallan;J. O'Beirne

  • Stromal features are predictive of disease mortality in oral cancer patients

    Daniel Marsh;Krishna Suchak;Karwan A Moutasim;Sabarinath Vallath

  • Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome

    N. J. Wald;A. K. Hackshaw

Frequent Co-Authors

Nicholas J. Wald
Nicholas J. Wald Queen Mary University of London
Charles Swanton
Charles Swanton The Francis Crick Institute
Nicholas McGranahan
Nicholas McGranahan University College London
Stephen W. Duffy
Stephen W. Duffy Queen Mary University of London
Jane Wardle
Jane Wardle University College London
Zoltan Szallasi
Zoltan Szallasi Boston Children's Hospital
Javier Herrero
Javier Herrero University College London
Christian H. Ottensmeier
Christian H. Ottensmeier University of Southampton
Sergio A. Quezada
Sergio A. Quezada University College London
Fiona H Blackhall
Fiona H Blackhall University of Manchester

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine opens doors to various alternative healthcare pathways, many of which can be started or advanced through online study. For those with a non-nursing background, msn direct entry programs online allow you to quickly transition into nursing careers by earning a master's degree without prior nursing experience.

Entry requirements can vary widely between programs. Prospective students often ask whats the easiest nursing program to get into? to find options with higher acceptance rates and flexible admissions policies. Some nursing schools even offer pathways that don't demand tough entrance exams, making it easier to get started. You can explore a list of nursing schools that don't require teas to simplify your application process.

Not all healthcare careers require a lengthy or expensive education. Medical billing and coding is a popular field, and there are many financial aid for medical billing and coding opportunities to help reduce tuition costs. Whether your interest lies in nursing or allied health roles, online programs can provide a convenient and practical pathway.

Best Scientists Citing Allan Hackshaw

Trending Scientists

Recently Published Articles